Big Pharma: Is Paying Big Fines More Profitable than Telling Doctors and Consumers the Truth in Marketing?

This week, Johnson & Johnson etched its name in the history books of another big pharma company that has been fined over billions of dollars due to a drug manufacturer practices of improper marketing and failure to warn.  Johnson & Johnson pled guilty to claims stemming from allegations that the giant pharmaceutical company knowingly marketed [...]

United Kingdom Seeks to Eliminate the Use of Metal-on-Metal Implants Due to High Failure Rate

Because of the high failure rates of metal on metal hip devices, and the potential for toxic exposure, the United Kingdom is moving to ban all metal-on-metal hip replacements performed at National Health Service [NHS] hospitals.  NHS is the publicly funded health care system in the U.K, the NHS seeks to stop these surgeries with [...]

DePuy September 23, 2013 Bellwether Trial Continued

On September 20, the Honorable David Katz presiding over the DePuy bellwether case, Ann McCracken v. DePuy Orthopaedics, Inc., et. al., Case No. 11 dp 20485, continued the trial 90 days from September 24, 2013 “in the interest of justice”.  According to the Order, the Judge continued the trial so that the parties could complete [...]

September 23rd, 2013|DePuy Hip Replacement, Drug and Medical Device Litigation|0 Comments

Johnson & Johnson Recalls Another DePuy Orthopedic Product

Johnson & Johnson (J&J) is no stranger to controversy.  From being embroiled in massive litigation in DePuy ASR artificial hips, Pinnacle litigation, and in the transvaginal mesh litigation with its Ethicon Gynecare products to its multiple legal troubles and fines associated with the anti-psychotic drug Risperdal, some things do not change for J&J – they [...]

Risperdal Continues to Boggle Down Johnson & Johnson

Trouble is no stranger to Johnson & Johnson.  Johnson and Johnson (J&J), embroiled in massive litigation in DePuy ASR artificial hips, and in transvaginal mesh litigation from its Ethicon Gynecare products, faces more legal issues from its anti-psychotic drug, Risperdal.  Currently, Johnson & Johnson is appealing a 1.2 billion dollar fine issued in an Arkansas [...]

June 24th, 2013|Uncategorized|0 Comments

510(k); Pathway for Safer drugs or Recipe for Disaster

Recent medical disasters such as the DePuy ASR, DePuy Pinnacle, and transvaginal mesh cases have revealed that medical devices were approved for use without adequate clinical data based on a grandfathering type provision in the FDA called a 510(k) process, where a new device that is cleared as "substantially equivalent" as a previously approved device [...]

Are Too Many Doctors Simply Sales People for Big Pharma?

Big Pharma paid doctors more than $1 billion in 2012 to act in various spokesperson capacities, for travel and meals, as well as research and royalties, which is significantly more than reported in 2011.  According to a new data reported in the Financial Times, that figure only includes the 12 leading drug makers who actually [...]

Who is Responsible for J&J’s DePuy ASR, Pinnacle, Ethicon’s Gynecare, and Merck’s Vioxx and Fosamax?

Consumers injured by defective devices face an armada of attorneys as they seek to hold accountable device makers such as J&J’s hip implants DePuy ASR, DePuy Pinnacle, J&J’s transvaginal mesh product Ethicon, and Merck’s FOSAMAX that has left countless post menopausal women with atypical femur fractures.  Currently there are over 10,000 pending cases in the [...]